LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,416,129
تعداد دریافت فایل اصل مقاله11,291,854
Moradi, Saeed, Razavi, Bibi Marjan, Moushekhian, Siavash, Poormahmood, Narges, Marvi, Mohammad. (1401). Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation. سامانه مدیریت نشریات علمی, 24(1), 41-46. doi: 10.30476/dentjods.2022.91452.1583
Saeed Moradi; Bibi Marjan Razavi; Siavash Moushekhian; Narges Poormahmood; Mohammad Marvi. "Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation". سامانه مدیریت نشریات علمی, 24, 1, 1401, 41-46. doi: 10.30476/dentjods.2022.91452.1583
Moradi, Saeed, Razavi, Bibi Marjan, Moushekhian, Siavash, Poormahmood, Narges, Marvi, Mohammad. (1401). 'Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation', سامانه مدیریت نشریات علمی, 24(1), pp. 41-46. doi: 10.30476/dentjods.2022.91452.1583
Moradi, Saeed, Razavi, Bibi Marjan, Moushekhian, Siavash, Poormahmood, Narges, Marvi, Mohammad. Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation. سامانه مدیریت نشریات علمی, 1401; 24(1): 41-46. doi: 10.30476/dentjods.2022.91452.1583

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation

Journal of Dentistry
مقاله 7، دوره 24، شماره 1 - شماره پیاپی 78، خرداد 2023، صفحه 41-46    اصل مقاله (724.71 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/dentjods.2022.91452.1583
نویسندگان
Saeed Moradi1؛ Bibi Marjan Razavi2؛ Siavash Moushekhian3؛ Narges Poormahmood4؛ Mohammad Marvi* 5
1Dental Material Research Center, Dept. of Endodontics, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
2Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Dept. of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
3Dental Research Center, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
4Pharmacist, Mashhad, Iran.
5Dept. of Endodontics, School of Dentistry, Mashhad University of Medical Science, Mashhad, Iran.
چکیده
Statement of the Problem: One of the rare adverse effects in patients who take bisphosphonates is the osteonecrosis of the jaw in the oral cavity following any trauma such as tooth extraction.
Purpose: The aim of this study is the histopathological evaluation of the jaw following intra-ligament anesthesia injection in Zoledronate-treated rats.
Materials and Method: In this descriptive-experimental study, rats weighing 200-250 g were divided into 2 groups. The first group received a 0.6 mg/kg dose of zoledronate and the second group received normal saline. Five injections with a 28-day interval were performed. At the end of the injection, the animals were sacrificed. Then, five-micrometer histological slides were prepared from the first maxillary molars and the surrounding tissues. Hematoxylin and eosin staining was performed to evaluate osteonecrosis, infiltration of inflammatory cells, fibrosis, and root and bone resorption.
Results: There was no difference between the macroscopic and clinical features in both groups and no evidence of osteonecrosis of the jaw was observed in the samples. From the histological point of view, all the samples had normal tissues and none of them showed any evidence of inflammation, tissue fibrosis, disorder, or pathological root resorption.
Conclusion: According to the histological findings, the periodontal ligament space, the bone adjacent to the roots, and the dental pulp conditions were similar in both groups. Osteonecrosis of the jaw did not develop in the rats that took bisphosphonates after intraligamental injection.
کلیدواژه‌ها
Bisphosphonates؛ Zoledronic Acid؛ Bisphosphonate-Associated Osteonecrosis of the Jaw
سایر فایل های مرتبط با مقاله
مراجع
  • Froughreyhani M, Salem Milani A, Barakatein B, Shiezadeh V. Treatment of strip perforation using root mta: a case report. Iran Endod J. 2013; 8: 80-83.
  • Rozental TD, Vazquez MACA, Chacko AT, Ayogu N, Bouxsein ML. Comparison of radiographic fracture healing in distal radius for patients on and off bisphosphonate therapy. J Hand Surg Am. 2009; 34: 595-602.
  • Kates SL, Ackert-Bicknell CL. How do bisphosphonates affect fracture healing? Injury. 2016; 47: S65-S68.
  • Meganck JA, Begun DL, McElderry JD, Swick A, Kozloff KM, Goldstein SM, et al. Fracture healing with alendronate treatment in the Brtlmouse model of osteogenesis imperfecta. Bone. 2013; 56: 204-212.
  • Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/ osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005; 63:1567-1575.
  • Smith GN, Walton RE. Periodontal ligament injection: ditribution of injected solutions. Oral Surg Oral Med Oral Pathol. 1983; 55: 232-238.
  • Nusstein JCE, Reader A, Beck M, Weaver J. Anesthetic effectiveness of the supplemental intraligamentary injection, administered with a computer-controlled local anesthetic delivery system, in patients with irreversible pulpitis. J Endod. 2005; 31: 354-358.
  • Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats. Head Neck. 2011; 33: 199-207.
  • Chaplet M, Detry C, Deroanne C, Fisher LW, Castronovo V, Bellahcene A. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochem J. 2004; 384: 591-598.
  • Harokopakis-Hajishengallis E. Physiologic root resorption in primary teeth: molecular and histological events. J Oral Sci. 2007; 49: 1-12.
  • Golomb G, Langer R, Schoen FJ, Smith MS, Choi YM, Levy RJ. Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: dose-response and mechanistic studies. J Control Release. 1986; 4: 181-194.
  • Green JR, Müller K, Jaeggi KA. Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res. 1994; 9: 745-751.
  • Gronich N, Rennert G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol. 2013; 10: 625-642.
  • Harokopakis-Hajishengallis E. Physiologic root resorption in primary teeth: molecular and histological events. J Oral Sci. 2007; 49: 1-12.
  • Hill LF, Lumb GA, Mawer EB, Stanbury SW. Indirect i-
nhibition of the biosynthesis of 1, 25-dihydroxycholecal-ciferol in rats treated with a diphosphonate. Clin Sci. 1973; 44: 335-347.

  • Hillner BE, Ingle JN, Chlebowski RT, J. Gralow, Yee GC, Janjan NA, et al. American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003; 21: 4042-4057.
  • Hillner BE, Weeks JC, Desch CE, Smith TJ. Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol. 2000; 18: 72-79.
  • Hiraga T, Ninomiya T, Hosoya A, Nakamura H. Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats. Calcif Tissue Int. 2010; 86: 502-510.
  • Allam E, Allen Mr, Chu TM, Ghoneima A, Jack*Windsor L. In vivo effects of zoledronic acid on oral mucosal epithelial cells. Oral Dis. 2011; 17: 291-297.
  • Hollander W, Prusty S, Nagraj S, Kirkpatrick B, Paddock J, Colombo M. Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkey. Atherosclerosis. 1978; 31: 307-325.
  • Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases.protocol 19 aredia breast cancer study group. N Engl J Med. 1996; 12; 335: 1785-1791.
  • Pourgonabadi S, Mousavi SH, Tayarani-Najaran Z, Ghorbani A. Effect of zoledronate, a third-generation bisphosphonate, on proliferation and apoptosis of human dental pulp stem cells. Can J Physiol Pharmacol. 2018; 96: 137-144.
  • Pourgonabadi S, Ghorbani A, Tayarani*Najarn Z, Mousavi SH. In vitro assessment of alendronate toxic and apoptotic effects on human dental pulp stem cells. Iran J Basic Med Sci. 2018; 21: 905-910.
  • Jowsey J, Riggs BL, Kelly PJ, Hoffman DL, Bordier P. The treatment of osteoporosis with disodium ethane-1-hydroxy-1, 1-diphosphonate. J Lab Clin Med. 1971; 78: 574-584.
  • Atkin I, Ornoy A, Pita JC, Muniz OE, Agundez A, Castiglione G, et al. EHDP‐induced rachitic syndrome in rats is not reversed by vitamin D metabolites. Anat Rec. 1988; 220: 22-30.
  • Basso FG, Pansani TN, de*Oliveira CF, Turrioni APS, Soares DG, Hebling J, et al. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts. Braz Dent J. 2013; 24: 551-558.
  • Kilickap S, Ozdamar Y, Altundag MK, Dizdar O. A case report: zoledronic acid-induced anterior uveitis. Med Oncol. 2008; 25: 238-240.
  • Kobayashi YT, Hiraga A, Ueda L, Wang M, Matsumoto-Nakano K, Hata H, et al. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab. 2010; 28: 165-175.
  • Kramsch DM, Chan CT. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. Circ Res. 1978; 42: 562-571.
آمار
تعداد مشاهده مقاله: 663
تعداد دریافت فایل اصل مقاله: 482


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب